Horst & Graben Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Sell |
784
-75
| -9% | -$30.4K | 0.05% | 128 |
|
|
2025
Q1 | $427K | Sell |
859
-11
| -1% | -$5.47K | 0.08% | 103 |
|
|
2024
Q4 | $453K | Hold |
870
| – | – | 0.08% | 95 |
|
|
2024
Q3 | $538K | Buy |
870
+1
| +0.1% | +$618 | 0.1% | 85 |
|
|
2024
Q2 | $481K | Hold |
869
| – | – | 0.09% | 86 |
|
|
2024
Q1 | $505K | Hold |
869
| – | – | 0.1% | 85 |
|
|
2023
Q4 | $461K | Buy |
869
+1
| +0.1% | +$531 | 0.1% | 80 |
|
|
2023
Q3 | $439K | Hold |
868
| – | – | 0.11% | 84 |
|
|
2023
Q2 | $453K | Sell |
868
-175
| -17% | -$91.3K | 0.11% | 78 |
|
|
2023
Q1 | $601K | Buy |
1,043
+1
| +0.1% | +$576 | 0.15% | 65 |
|
|
2022
Q4 | $574K | Buy |
1,042
+1
| +0.1% | +$551 | 0.15% | 73 |
|
|
2022
Q3 | $528K | Hold |
1,041
| – | – | 0.15% | 71 |
|
|
2022
Q2 | $566K | Buy |
1,041
+1
| +0.1% | +$544 | 0.15% | 71 |
|
|
2022
Q1 | $614K | Hold |
1,040
| – | – | 0.15% | 67 |
|
|
2021
Q4 | $694K | Buy |
1,040
+1
| +0.1% | +$667 | 0.17% | 61 |
|
|
2021
Q3 | $594K | Hold |
1,039
| – | – | 0.16% | 68 |
|
|
2021
Q2 | $524K | Hold |
1,039
| – | – | 0.15% | 76 |
|
|
2021
Q1 | $474K | Buy |
1,039
+1
| +0.1% | +$456 | 0.15% | 83 |
|
|
2020
Q4 | $484K | Hold |
1,038
| – | – | 0.17% | 72 |
|
|
2020
Q3 | $458K | Buy |
1,038
+1
| +0.1% | +$441 | 0.18% | 65 |
|
|
2020
Q2 | $376K | Hold |
1,037
| – | – | 0.17% | 69 |
|
|
2020
Q1 | $294K | Buy |
+1,037
| New | +$294K | 0.15% | 71 |
|